dermaGPT
ResourcesContact Us
Book a Demo

Give us the claims.
Get the claims compliance report.

Compliance, AI computed.

A claim is a promise the file has to keep. dermaGPT reads the pack, the product page and the campaign copy, classifies each claim, checks it against the criteria that apply in each market and tells you what evidence it needs, before an authority or a competitor asks.

Book a dermaGPT demo

In the EU the proof of the effect claimed belongs in the PIF itself (Article 11(2)(d)). A claim without evidence is not a marketing problem; it is a gap in the file.

What the rules say about claims

Binding criteria in the EU, a drug line in the US, and guidance that keeps narrowing 'free from'.

01European Union

Six common criteria

Regulation (EU) No 655/2013 binds every claim to legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making, whatever the medium.

02Evidence

Proof in the file

Article 11(2)(d) of Regulation (EC) No 1223/2009 requires proof of the effect claimed in the Product Information File where the nature or effect of the product justifies it. Regulation (EU) No 655/2013 sets the standard: adequate, verifiable evidence consistent with the type of claim.

03Guidance

'Free from' and 'hypoallergenic'

The 2017 Technical Document on cosmetic claims, non-binding guidance from the Commission-chaired working group that authorities have applied since July 2019, advises against 'free from' claims that denigrate legally used ingredients or merely restate the law (Annex III), and expects 'hypoallergenic' to rest on evidence of minimised allergenic potential, with no known allergens (Annex IV).

04United States

The cosmetic-versus-drug line

A claim that a product treats or prevents disease, or affects the structure or function of the body, makes it a drug (or a drug and a cosmetic) under the FD&C Act, however it is marketed. The FTC requires a reasonable basis before a claim is published, and competent and reliable scientific evidence for objective efficacy claims.

Give us the copy, get the report

Pack, product page, social and campaign copy, in every language; the platform extracts the claims and checks each one.

What you give us

  1. 01Label artwork and pack copy
  2. 02Product pages, campaign and social copy
  3. 03Any test reports, consumer studies or supplier data behind the claims
  4. 04The markets the product is advertised in

What you get

  1. 01Every claim extracted and classified: performance, ingredient, 'free from', sensory, environmental, comparative
  2. 02A verdict per claim and market against the six criteria, the technical document and the US drug line, with the citation
  3. 03The evidence each claim needs, and whether what you hold is enough
  4. 04Rewording for claims that cannot be kept as written
  5. 05The proof-of-effect dossier for the PIF (Article 11(2)(d)), ready for the assessor and the file

How claims are reviewed

Four steps from copy to claims the file can keep.

01

Extract the claims

Every statement that promises an effect, an ingredient property or an absence is pulled from pack, web and campaign copy, in each language.

02

Classify and map

Each claim is typed and mapped to the rule that governs it in each market, including the 'free from' and 'hypoallergenic' guidance.

03

Check the evidence

What the claim needs is compared with what you hold: test data, consumer study, published literature, or nothing.

04

Report and reword

Each claim gets a verdict, the evidence gap and, where needed, a wording that keeps the message within the rules.

What reopens the claims review

Claims age faster than formulas.

Triggers

New campaign or channel
Copy written for social or a marketplace carries claims the pack never made.
Reformulation
An ingredient removed or added changes which 'free from' and ingredient claims are still true.
Guidance update
National guidance and the EU's new rules on environmental claims keep narrowing what 'free from', 'natural' and 'green' claims may say.
Complaint or challenge
A competitor or authority challenge needs the evidence file to be ready on the day it arrives.
New market
The US drug line and advertising rules differ from the EU criteria; the same claim can pass in one and fail in the other.

Our strengths

Beyond compliance documentation.

Verify the data behind every compliance decision.

Not just generating compliance documents: verifying the data and the evidence behind every compliance judgement.

Three reasons to choose dermaGPT

  • 01

    Regulatory Intelligence

    Complex regulations compiled into executable check logic.

  • 02

    Data Verification

    Recalculate and cross-check to surface inconsistencies and latent problems.

  • 03

    Evidence Traceability

    Every finding traces back to the source document, page and revision.

dermaGPT in numbers

Documents processed
1,000,000+
13,000× faster time-to-market
10 min
Botanical studies analyzed
20,000+
Trusted by 500+ businesses

Manual report preparation

2 months per product

With dermaGPT

As fast as 10 minutes

Evidence collection and the assessor's review are separate steps; the file itself is generated in minutes.

Read more

  • What is a Product Information File?
  • PIF vs CPSR
  • What is MoCRA?
  • What is a cosmetic safety assessment?

Every ingredient, every market

  • Every ingredient cleared for every market.

  • Signed by qualified assessors.

  • Rule changes, mapped to your products.

  • Inspection-ready at any moment.

  • One record, every market.

See dermaGPT on your own products.

A short walkthrough with our team, built around your formulas and the markets you sell in.

Book a Demo

Unlock growth with dermaGPT

Learn how systematic AI can optimize formula performance and elevate product portfolio outcomes.

dermaGPT

End-to-end AI solutions for R&D efficacy prediction, production compliance, and smart recommendations.

Product

  • Home
  • Markets
  • Resources
  • FAQ

Solutions

  • EU PIF / CPSR
  • US MoCRA
  • ASEAN PIF
  • PPWR Technical Documentation
  • Label Compliance Report
  • Claims & Advertising Compliance Report
  • REACH / CLP Compliance Report

About

  • Privacy Policies
  • Cookies Policy

Headquarters

VesCir Ltd.

10F.-1, No. 155, Sec. 3, Xinyi Rd., Da'an Dist., Taipei City 106, Taiwan

+886 2 2507 6729

service@vescir.com

Netherlands Branch

VesCir Holland BV

WTC The Hague, Prinses Margrietplantsoen 33, 2595 AM Den Haag, The Netherlands

service@vescir.com

©2026 dermaGPT|All rights reserved